Foscarnet
CMV Retinitis in AIDS patients
Mucocutaneous Acyclovir-Resistant HSV Infections in immunocompromised individuals
CMV: 60 mg/kg every 8h or 90 mg/kg every 12h for 2–3 weeks
HSV: 40 mg/kg every 8–12h until lesions heal
Most common: Fever (65%), nausea (47%), anemia (33%), diarrhea (30%), abnormal renal function (27%), seizures (10%)
Severe AEs: Death (14%), renal dysfunction (14%), marrow suppression (10%)
Post-marketing reports: Nephrotic syndrome, glomerulonephritis, QT prolongation, Fanconi syndrome, and rare dermatologic reactions like Stevens-Johnson syndrome
Foscarnet sodium injection is contraindicated in patients with clinically significant hypersensitivity to foscarnet sodium.
Renal Impairment: The most serious toxicity. Requires close monitoring of serum creatinine and creatinine clearance.
Seizures: May occur due to electrolyte imbalances, especially hypocalcemia.
Electrolyte Disturbances: Includes hypocalcemia, hypokalemia, hypomagnesemia, and more.
QT Prolongation and Torsades de Pointes: Risk increases with existing cardiac conditions or electrolyte issues.
Hypersensitivity Reactions: Including anaphylaxis, angioedema.